Ephrin-2 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of ephrin-2, a member of the ephrin family of ligands that interact with Eph receptors. Ephrins and Eph receptors are part of a larger signaling system that plays a crucial role in cell-cell communication, impacting processes like cell adhesion, migration, and cytoskeletal organization. The ephrin-2 ligand (also known as EFNB2) binds to Eph receptors, predominantly from the EphB subclass, triggering bidirectional signaling that affects both the ligand-expressing and receptor-expressing cells. Inhibitors of ephrin-2 can interfere with this signaling pathway by preventing the binding of ephrin-2 to its respective Eph receptors, thereby modulating various cellular behaviors controlled by this signaling axis. These inhibitors are structurally diverse and can include small molecules, peptides, or biologically derived molecules designed to disrupt ephrin-2's interaction with Eph receptors.
The mechanism of action of ephrin-2 inhibitors is generally based on their ability to either block the binding site of ephrin-2 on its corresponding receptors or to alter the conformation of the ligand or receptor to prevent their interaction. This inhibition can affect downstream signaling pathways such as Rho family GTPases, phosphoinositide 3-kinase (PI3K), and mitogen-activated protein kinase (MAPK) pathways, which are linked to changes in cell shape, movement, and cellular proliferation. Additionally, ephrin-2 inhibitors can influence cellular functions like axon guidance, angiogenesis, and boundary formation during development. Because ephrin-2 is membrane-bound and requires cell-cell contact to engage with Eph receptors, inhibitors of ephrin-2 can profoundly impact the dynamics of cellular interaction in tissues where ephrin-Eph signaling is prevalent. The structural variability among ephrin-2 inhibitors allows for differential specificity and affinity towards ephrin-2 and its receptors, offering a broad range of tools for studying and modulating cell signaling pathways regulated by the ephrin-Eph system.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent could downregulate ephrin-2 by inducing the demethylation of its gene promoter, thereby repressing transcription initiation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This histone deacetylase inhibitor may lead to hyperacetylation of histones near the ephrin-2 gene, reducing transcriptional initiation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
This compound may decrease ephrin-2 expression by causing hyperacetylation of histone proteins, thereby altering the accessibility of its promoter. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This could inhibit RNA polymerase from transcribing the ephrin-2 gene by intercalating into DNA and blocking the elongation phase. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
This compound may inhibit ephrin-2 protein synthesis by obstructing the peptidyl transferase activity of ribosomes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
This immunosuppressant might decrease ephrin-2 expression by specifically inhibiting mTOR, crucial for cap-dependent protein translation initiation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This inhibitor may reduce ephrin-2 levels by blocking PI3K, thus attenuating the activation of downstream transcription factors. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
This inhibitor could decrease ephrin-2 transcription by inhibiting the JNK pathway, which is potentially involved in its gene's expression control. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This MEK inhibitor might reduce ephrin-2 expression by preventing the phosphorylation of MAPK/ERK, thereby inhibiting downstream transcription factors. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
This MEK inhibitor could lead to a decrease in ephrin-2 expression by blocking the MAPK/ERK signaling pathway and its transcriptional control. | ||||||